Avalo Therapeutics Inc
NASDAQ:AVTX
Avalo Therapeutics Inc
NASDAQ:AVTX
Price:
21.545
USD
32.5%
Market Cap:
$575.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Avalo Therapeutics Inc
NASDAQ:AVTX
|
US |
|
Conduent Inc
NASDAQ:CNDT
|
US |
|
Roku Inc
NASDAQ:ROKU
|
US |
|
E
|
ENGIE Energia Chile SA
SGO:ECL
|
CL |
|
OP Bancorp
NASDAQ:OPBK
|
US |
|
Inventiva SA
PAR:IVA
|
FR |
|
AstraZeneca PLC
LSE:AZN
|
UK |
|
Starbucks Corp
NASDAQ:SBUX
|
US |
|
Trent Ltd
NSE:TRENT
|
IN |
|
EOG Resources Inc
NYSE:EOG
|
US |
Wall St Price Targets
AVTX Price Targets Summary
Avalo Therapeutics Inc
Avalo Therapeutics Inc
Wall Street analysts forecast AVTX stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for AVTX is 40.46 USD with a low forecast of 24.24 USD and a high forecast of 54.6 USD.
Lowest Forecast
Price Target
24.24
USD
13% Upside
Average Forecast
Price Target
40.46
USD
88% Upside
Highest Forecast
Price Target
54.6
USD
153% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AVTX's stock price target?
Price Target
40.46
USD
40.46
USD
According to Wall Street analysts, the average 1-year price target for AVTX is 40.46 USD with a low forecast of 24.24 USD and a high forecast of 54.6 USD.
What is the Revenue forecast for Avalo Therapeutics Inc?
Projected CAGR
209%
209%
Over the last 13 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 8 years is 209%.
